Drugmaker AbbVie expects Humira volume erosion to worsen
By Leroy Leo and Christy Santhosh (Reuters) -AbbVie expects a drop in sales volumes of its blockbuster arthritis drug Humira to deepen after recent changes by U.S. pharmacy benefit managers and as patients shift to other drugs. Its shares were...